ArticleFrontiers in pharmacology2021

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients.

Juanfang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.